NRC — National Research Cashflow Statement
0.000.00%
Last trade - 00:00- $360.84m
- $435.73m
- $137.39m
- 95
- 46
- 64
- 78
Annual cashflow statement for National Research, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 8-K |
| Standards: | USG | USG | USG | USG | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 37.5 | 31.8 | 31 | 24.8 | 11.6 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.94 | 4.27 | 1.34 | 0.642 | 3.86 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.84 | -3.35 | 1.02 | 3.84 | 0.916 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | 46.3 | 36.3 | 38.1 | 34.6 | 26.4 |
| Capital Expenditures | -5.51 | -9.84 | -15.8 | -15.4 | -10.7 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -3 | — | 0.001 | -4.83 | 0 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -8.51 | -9.84 | -15.8 | -20.3 | -10.7 |
| Financing Cash Flow Items | -0.721 | -2.23 | -0.008 | -0.359 | -1.06 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -18.2 | -55.6 | -40.7 | -16.8 | -15.8 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 19.7 | -29.3 | -18.4 | -2.42 | -0.094 |